X
MDXG icon

Xponance’s MiMedx Group MDXG Stock Holding History

Xponance’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Buy
11,536
+813
+8% +$2.97K ﹤0.01% 1797
2026
Q1 		$42.4K Buy
+10,723
New +$54K ﹤0.01% 1643
2024
Q2 		– Sell
-15,337
Closed -$118K – 1348
2024
Q1 		$118K Buy
15,337
+266
+2% +$2.14K ﹤0.01% 1231
2023
Q4 		$132K Sell
15,071
-1,071
-7% -$7.84K ﹤0.01% 1192
2023
Q3 		$118K Sell
16,142
-859
-5% -$6.4K ﹤0.01% 1156
2023
Q2 		$112K Buy
+17,001
New +$86.7K ﹤0.01% 1185

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Xponance's MDXG Position: Q2 2026 in Review

Xponance increased its MiMedx Group (MDXG) stake by 7.6% in Q2 2026, buying an estimated $2.97K and bringing the position to 11,536 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

Xponance first reported a position in MDXG in Q2 2023 and has held it in 6 quarters since. The position peaked at $132K in Q4 2023. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Xponance held 11,536 shares of MiMedx Group worth $44.4K as of Q2 2026.
  • Xponance bought 813 MiMedx Group shares in Q2 2026, an estimated $2.97K.
  • MiMedx Group made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1797 holding.
  • Xponance first reported a position in MiMedx Group in Q2 2023 and has held it in 6 quarters since.
  • Xponance's MiMedx Group position peaked at $132K in Q4 2023.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.